ÌìÃÀ´«Ã½

Proposed Uses

This technology is well-suited for healthcare providers, diagnostics companies, and agricultural organisations that require rapid, quantitative testing in field. It addresses markets including human disease detection, food safety testing, and crop pathogen screening, particularly where laboratory infrastructure is limited or unavailable.

Problem addressed

Standard laboratory diagnostic methods such as ELISA require specialist equipment and trained personnel, and can take 24–48 hours to return results. Lateral flow assays typically deliver only qualitative (positive/negative) outputs with limited sensitivity, and lack connectivity with digital health systems. This analytical gap created a significant unmet need for a portable, quantitative, and digitally connected diagnostic platform.

Technology Overview

The platform integrates electrochemical sensing directly into a lateral flow assay format, enabling quantitative measurement of target biomarkers without a separate laboratory instrument. Results are transmitted wirelessly to a standard smartphone and stored securely in the cloud, enabling real-time remote monitoring and analysis. The device is low-cost and disposable, requires no specialist training, and has been validated in field conditions, making it practical for deployment across healthcare, agricultural, and environmental monitoring applications.

Benefits

• Quantitative results in under 5 minutes, replacing tests that take 24–48 hours
• Fully portable with smartphone readout, no laboratory equipment required
• Cloud connectivity enables real-time remote monitoring and data management
• Low-cost, disposable format suited for large-scale or repeated deployment